{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T16:11:19Z","timestamp":1660666279844},"reference-count":19,"publisher":"Japanese Society of Veterinary Science","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Veterinary Medical Science","J. Vet. Med. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1292\/jvms.17-0018","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T22:07:30Z","timestamp":1493590050000},"page":"1031-1034","source":"Crossref","is-referenced-by-count":3,"title":["Long term effects of cilostazol in a dog with sick sinus syndrome"],"prefix":"10.1292","volume":"79","author":[{"given":"Nobuyuki","family":"KANNO","sequence":"first","affiliation":[{"name":"Division of Veterinary Cardiovascular Medicine and Surgery, Laboratory of Veterinary Medical Therapeutics, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, 1866 Kameino, Fujisawa-shi, Kanagawa 252-0880, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"SUZUKI","sequence":"additional","affiliation":[{"name":"Ikime Animal Hospital, 3036-4 Ukita, Ooaza, Miyazakishi, Miyazaki 880-2104, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","unstructured":"1. Akiyama, H., Kudo, S. and Shimizu, T. 1985. The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. <i>Arzneimittelforschung<\/i> 357A: 1124\u20131132."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Atarashi, H., Endoh, Y., Saitoh, H., Kishida, H. and Hayakawa, H. 1998. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. <i>J. Cardiovasc. Pharmacol.<\/i> 31: 534\u2013539.","DOI":"10.1097\/00005344-199804000-00010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ebisawa, T., Ohta, Y., Funayama, M., Yamano, S., Mizuno, M., Mizuno, T., Kasuya, A., Sawada, T., Lee, J., Mizukoshi, T. and Uechi, M. 2013. Plasma atrial natriuretic peptide is an early diagnosis and disease severity marker of myxomatous mitral valve disease in dogs. <i>Res. Vet. Sci.<\/i> 94: 717\u2013721.","DOI":"10.1016\/j.rvsc.2012.12.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Johnson, M. S., Martin, M. W. and Henley, W. 2007. Results of pacemaker implantation in 104 dogs. <i>J. Small Anim. Pract.<\/i> 48: 4\u201311.","DOI":"10.1111\/j.1748-5827.2006.00190.x"},{"key":"5","unstructured":"5. Kato, R. 2006. Efficacy of PDE III inhibitor cilostazol in sick sinus syndrome. <i>Jpn. J. Clin. Exp. Med.<\/i> 83: 1383\u20131387 (in Japanese)."},{"key":"6","unstructured":"6. Kawamura, K., Fujita, S., Tani, T. and Kimura, Y. 1985. Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency. <i>Arzneimittelforschung<\/i> 357A: 1154\u20131156."},{"key":"7","unstructured":"7. Kimura, Y., Tani, T., Kanbe, T. and Watanabe, K. 1985. Effect of cilostazol on platelet aggregation and experimental thrombosis. <i>Arzneimittelforschung<\/i> 357A: 1144\u20131149."},{"key":"8","unstructured":"8. Kittlesson, M. D. and Kienle, R. D. 1998. pp. 455\u2013460. <i>In<\/i>: Small Animal Cardiovascular Medicine. Mosby Inc., St. Louis."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kodama-Takahashi, K., Kurata, A., Ohshima, K., Yamamoto, K., Uemura, S., Watanabe, S. and Iwata, T. 2003. Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block. <i>Chest<\/i> 123: 1161\u20131169.","DOI":"10.1378\/chest.123.4.1161"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Moriya, I., Takahashi, T., Nomura, Y., Kawaura, K., Kusaka, K., Yamakawa, J., Fujioka, N., Okubo, S., Itoh, T. and Kanda, T. 2004. Chronotropic effect of the antithrombotic agent cilostazol in a patient with sick sinus syndrome and syncope. <i>J. Int. Med. Res.<\/i> 32: 549\u2013551.","DOI":"10.1177\/147323000403200513"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ng Kam Chuen, M. J., Kirkfeldt, R. E., Andersen, H. R. and Nielsen, J. C. 2014. Syncope in paced patients with sick sinus syndrome from the DANPACE trial: incidence, predictors and prognostic implication. <i>Heart<\/i> 100: 842\u2013847.","DOI":"10.1136\/heartjnl-2013-304976"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nimura, A., Sato, N., Sakuragi, H., Koyama, S., Maruyama, J., Talib, A. K., Nakagawa, N., Sakamoto, N., Ota, H., Tanabe, Y., Takeuchi, T., Kawamura, Y. and Hasebe, N. 2011. Recovery of advanced atrioventricular block by cilostazol. <i>Intern. Med.<\/i> 50: 1957\u20131961.","DOI":"10.2169\/internalmedicine.50.5228"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rubenstein, J. J., Schulman, C. L., Yurchak, P. M. and DeSanctis, R. W. 1972. Clinical spectrum of the sick sinus syndrome. <i>Circulation<\/i> 46: 5\u201313.","DOI":"10.1161\/01.CIR.46.1.5"},{"key":"14","unstructured":"14. Shintani, S., Watanabe, K., Kawamura, K., Mori, T., Tani, T., Toba, Y., Sasabe, H., Nakagiri, N., Hongoh, O., Fujita, S., Aogi, T., Kido, Y., Umezato, M., Ishikawa, M. and Hiyama, M. 1985. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs. <i>Arzneimittelforschung<\/i> 357A: 1163\u20131172."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Toyonaga, S., Nakatsu, T., Murakami, T., Kusachi, S., Mashima, K., Tominaga, Y., Yamane, S., Uesugi, T., Kanai, H. and Tsuji, T. 2000. Effects of cilostazol on heart rate and its variation in patients with atrial fibrillation associated with bradycardia. <i>J. Cardiovasc. Pharmacol. Ther.<\/i> 5: 183\u2013191.","DOI":"10.1054\/JCPT.2000.8696"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tsukamoto, M., Imai, S., Yagi, H. and Kamimatsuse, K. 2003. Effect of cilostazol on cardiac arrest in patients with sick sinus syndrome <i>Jpn<\/i>. <i>J. Electrocardiol.<\/i> 23: 587\u2013595 (in Japanese).","DOI":"10.5105\/jse.23.587"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ward, J. L., DeFrancesco, T. C., Tou, S. P., Atkins, C. E., Griffith, E. H. and Keene, B. W. 2016. Outcome and survival in canine sick sinus syndrome and sinus node dysfunction: 93 cases (2002\u20132014). <i>J. Vet. Cardiol.<\/i> 18: 199\u2013212.","DOI":"10.1016\/j.jvc.2016.04.004"},{"key":"18","unstructured":"18. Wess, G., Thomas, W. P., Berger, D. M. and Kittleson, M. D. 2006. Applications, complications, and outcomes of transvenous pacemaker implantation in 105 dogs (1997\u20132002). <i>J. Vet. Intern. Med.<\/i> 20: 877\u2013884."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamashita, S., Miyagawa, K., Inagaki, T. and Dohi, Y. 1999. [Cilostazol increased heart rate with improvement of activity of daily living in an elderly patient with sick sinus syndrome]. <i>Nippon Ronen Igakkai Zasshi<\/i> 36: 561\u2013564 (in Japanese).","DOI":"10.3143\/geriatrics.36.561"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/79\/6\/79_17-0018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T15:44:49Z","timestamp":1498405489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/79\/6\/79_17-0018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.17-0018","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}